Jérôme Lambert

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau, Michel Attal, Cyrille Hulin et al. · The Lancet · 2019 · 953 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study

Élie Azoulay, Djamel Mokart, Frédéric Pène et al. · Journal of Clinical Oncology · 2013 · 645 citations · Full text

Medicine, Hematology, Oncology +13

Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure: Randomized Controlled Trial

Élie Azoulay, Djamel Mokart, Jérôme Lambert et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 301 citations

Medicine, Hematology, Oncology +16

Toward a <i>NOTCH1/FBXW7/RAS/PTEN</i> –Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study

Amélie Trinquand, Aline Schmidt, Raouf Ben Abdelali et al. · Journal of Clinical Oncology · 2013 · 250 citations · Full text

Medicine, Hematology, Oncology +15

Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients

Frédérik Damm, Elena Mylonas, Adrien Cosson et al. · Cancer Discovery · 2014 · 249 citations

Life Sciences, Genetics, Hematology +17